%	O
%	O
TITLE	O

Human	O
papillomavirus	O
infection	O
in	O
oral	O
squamous	O
cell	O
carcinomas	O
from	O
Chilean	B-Study_Location
patients	O
.	O

%	O
%	O
ABSTRACT	O

Human	O
papillomavirus	O
(	O
HPV	O
)	O
is	O
the	O
causal	O
agent	O
of	O
cervical	O
,	O
anogenital	O
and	O
a	O
subset	O
of	O
oropharyngeal	O
carcinomas	O
.	O

In	O
addition	O
,	O
the	O
role	O
of	O
HPV	O
in	O
oral	O
carcinogenesis	O
has	O
been	O
suggested	O
,	O
although	O
the	O
findings	O
are	O
inconclusive	O
.	O

In	O
this	O
study	O
,	O
using	O
conventional	O
polymerase	B-HPV_Lab_Technique
chain	I-HPV_Lab_Technique
reaction	I-HPV_Lab_Technique
(	I-HPV_Lab_Technique
PCR	I-HPV_Lab_Technique
)	I-HPV_Lab_Technique
and	O
genotyping	B-HPV_Lab_Technique
by	I-HPV_Lab_Technique
specific	I-HPV_Lab_Technique
PCR	I-HPV_Lab_Technique
and	O
DNA	O
sequencing	O
,	O
we	O
analyzed	O
the	O
HPV	O
presence	O
in	O
80	B-Study_Cohort
oral	I-Study_Cohort
squamous	I-Study_Cohort
cell	I-Study_Cohort
carcinomas	I-Study_Cohort
(	I-Study_Cohort
OSCCs	I-Study_Cohort
)	I-Study_Cohort
from	O
Chilean	B-Study_Location
subjects	O
.	O

In	O
addition	O
,	O
we	O
determined	O
the	O
expression	B-HPV_Lab_Technique
of	I-HPV_Lab_Technique
p16	I-HPV_Lab_Technique
,	I-HPV_Lab_Technique
p53	I-HPV_Lab_Technique
,	I-HPV_Lab_Technique
pRb	I-HPV_Lab_Technique
and	I-HPV_Lab_Technique
Ki	I-HPV_Lab_Technique
-	I-HPV_Lab_Technique
67	I-HPV_Lab_Technique
using	I-HPV_Lab_Technique
immunohistochemistry	I-HPV_Lab_Technique
(	I-HPV_Lab_Technique
IHC	I-HPV_Lab_Technique
)	I-HPV_Lab_Technique
.	O

The	O
CDKN2A	O
(	O
p16	O
)	O
promoter	O
methylation	O
was	O
evaluated	O
using	O
methylation	B-HPV_Lab_Technique
-	I-HPV_Lab_Technique
specific	I-HPV_Lab_Technique
PCR	I-HPV_Lab_Technique
(	I-HPV_Lab_Technique
MSP	I-HPV_Lab_Technique
)	O
.	O

HPV	O
sequences	O
were	O
found	O
in	O
9	O
/	O
80	O
(	O
11	O
%	O
)	O
OSCCs	O
.	O

Non	O
-	O
statistically	O
significant	O
association	O
with	O
p53	O
,	O
pRb	O
,	O
Ki	O
-	O
67	O
and	O
p16	O
levels	O
were	O
found	O
(	O
p=0	O
.	O
77	O
;	O
0	O
.	O
29	O
;	O
0	O
.	O
83	O
;	O
0	O
.	O
21	O
,	O
respectively	O
)	O
.	O

HPV	O
-	O
16	O
and	O
18	O
were	O
the	O
most	O
prevalent	B-Incidence_or_Prevalence
HPV	O
genotypes	O
in	O
8	O
/	O
9	O
(	O
89	O
%	O
)	O
OSCCs	O
.	O

In	O
addition	O
,	O
CDKN2A	O
(	O
p16	O
)	O
was	O
methylated	O
in	O
39	O
%	O
of	O
OSCCs	O
.	O

No	O
association	O
with	O
HPV	O
presence	O
(	O
p=0	O
.	O
917	O
)	O
was	O
found	O
.	O

These	O
results	O
suggest	O
that	O
HPV	O
positive	O
OSCCs	O
are	O
entities	O
that	O
do	O
not	O
resemble	O
the	O
molecular	O
alterations	O
of	O
HPV	O
-	O
associated	O
tumors	O
in	O
a	O
Chilean	B-Study_Location
population	O
.	O

More	O
studies	O
are	O
warranted	O
to	O
determine	O
the	O
role	O
of	O
HPV	O
in	O
OSCCs	O
.	O

%	O
%	O
MATERIALS	O
AND	O
METHODS	O

Sample	B-HPV_Sample_Type
collection	O

3Eighty	O
OSCCs	O
were	O
collected	O
considering	O
a	O
database	O
from	O
the	O
Reg	O
-	O
ister	O
of	O
the	O
Pathological	O
anatomy	O
service	O
from	O
the	O
Faculty	O
of	O
Dentistry	O
,	O
University	O
of	O
Chile	B-Study_Location
(	O
SAP	O
-	O
FOUCH	O
)	O
,	O
between	O
the	O
years	O
2000	B-Study_Time
and	I-Study_Time
2014	I-Study_Time
and	O
from	O
the	O
National	O
Cancer	O
Institute	O
,	O
between	O
the	O
years	O
2013	B-Study_Time
and	I-Study_Time
2014	I-Study_Time
.	I-Study_Time

The	O
demographical	O
and	O
clinical	O
data	O
were	O
directly	O
obtained	O
from	O
the	O
clinical	O
record	O
.	O

The	O
study	O
was	O
approved	O
by	O
the	O
Ethical	O
Committee	O
Board	O
from	O
the	O
Faculty	O
of	O
Medicine	O
and	O
Faculty	O
of	O
Dentistry	O
,	O
University	O
of	O
Chile	B-Study_Location
.	O

DNA	O
extraction	O
and	O
polymerase	B-HPV_Lab_Technique
chain	I-HPV_Lab_Technique
reaction	I-HPV_Lab_Technique
(	I-HPV_Lab_Technique
PCR	I-HPV_Lab_Technique
)	I-HPV_Lab_Technique
for	O
HPV	O
presence	O

Parafﬁn	O
-	O
embedded	O
samples	B-HPV_Sample_Type
were	O
cut	O
into	O
10	O
μm	O
slices	O
and	O
prepared	O
according	O
to	O
a	O
previously	O
described	O
method	O
(	O
)	O
,	O
followed	O
by	O
digestion	O
with	O
proteinase	O
K	O
(	O
200	O
mg	O
/	O
mL	O
)	O
at	O
55	O
°C	O
overnight	O
.	O

The	O
integrity	O
status	O
of	O
DNA	O
was	O
conﬁrmed	O
by	O
PCR	B-HPV_Lab_Technique
for	O
a	O
110	O
base	O
pairs	O
(	O
bp	O
)	O
beta	O
-	O
globin	O
fragment	O
using	O
primers	O
PCO3	O
:	O
50	O
-	O
ACACAA	O
CTGTGTTCACTAGC	O
-	O
30	O
and	O
PCO4	O
:	O
50	O
-	O
CAACTTCATCCACGTTCACC	O
-	O
30	O
.	O

The	O
presence	O
of	O
HPV	O
DNA	O
was	O
evaluated	O
by	O
PCR	B-HPV_Lab_Technique
using	I-HPV_Lab_Technique
GP5	I-HPV_Lab_Technique
+	I-HPV_Lab_Technique
/	I-HPV_Lab_Technique
GP6	I-HPV_Lab_Technique
+	O
primers	O
(	O
150	O
bp	O
)	O
for	O
the	O
HPV	O
L1	O
gene	O
(	O
)	O
.	O

The	O
PCR	B-HPV_Lab_Technique
reaction	O
was	O
performed	O
in	O
a	O
total	O
volume	O
of	O
25	O
μL	O
containing	O
1	O
U	O
of	O
HotStar	O
Taq	O
(	O
Qiagen	O
,	O
Hilden	O
,	O
Germany	O
)	O
,	O
50	O
mM	O
of	O
each	O
primer	O
,	O

0	O
.	O
2	O
mM	O
of	O
each	O
dNTP	O
and	O
HotStar	O
Taq	O
PCR	B-HPV_Lab_Technique
buffer	O
as	O
supplied	O
by	O
the	O
en	O
-	O
zyme	O
manufacturer	O
(	O
Qiagen	O
)	O
(	O
contains	O
1	O
.	O
5	O
mM	O
MgCl2	O
,	O
Tris–Cl	O
,	O
KCl	O
,	O
(	O
NH4	O
)	O
2SO4	O
pH	O
8	O
.	O
7	O
)	O
.	O

The	O
ampliﬁcation	O
was	O
carried	O
out	O
with	O
initial	O
en	O
-	O
zyme	O
activation	O
at	O
95	O
°C	O
for	O
5	O
min	O
,	O
followed	O
by	O
45	O
cycles	O
that	O
included	O
a	O
1	O
min	O
denaturation	O
step	O
at	O
94	O
°C	O
,	O
a	O
2	O
min	O
annealing	O
step	O
at	O
40	O
°C	O
and	O
a	O
1	O
.	O
5	O
min	O
chain	O
elongation	O
step	O
at	O
72	O
°C	O
;	O
and	O
a	O
ﬁnal	O
elongation	O
at	O
72	O
°C	O
for	O
5	O
min	O
.	O

The	O
ampliﬁcation	O
of	O
HPV	O
-	O
16	O
and	O
-	O
18	O
was	O
carried	O
out	O
through	O
speciﬁc	O
PCR	B-HPV_Lab_Technique
in	O
generic	O
HPV	O
positive	O
samples	B-HPV_Sample_Type
.	O

The	O
primers	O
used	O
for	O
HPV	O
-	O
16	O
ampliﬁcation	O
were	O
:	O
Forward	O
:	O
5′	O
-	O
GGTCGGTGGACCGG	O
TCGATG	O
-	O
3′	O
and	O
Reverse	O
:	O
5′	O
-	O
GCAATGTAGGTGTATCTCCA	O
-	O
3′	O
and	O
for	O
HPV	O
-	O
18	O
ampliﬁcation	O
were	O
:	O
Forward	O
:	O
5′	O
-	O
CCTTGGACGTAAATTTTTGG	O
-	O
3′	O
and	O
Reverse	O
:	O
5′	O
-	O
CACGCACACGCTTGGCAGGT	O
-	O
3′	O
.	O

The	O
PCR	B-HPV_Lab_Technique
conditions	O
were	O
:	O
initial	O
denaturation	O
at	O
95	O
°C	O
for	O
5	O
min	O
followed	O
by	O
45	O
cycles	O
consisting	O
of	O
94	O
°C	O
for	O
45	O
s	O
,	O
55	O
°C	O
for	O
45	O
s	O
and	O
72	O
°C	O
for	O
45	O
s	O
and	O
a	O
ﬁnal	O
extension	O
at	O
72	O
°C	O
for	O
5	O
min	O
.	O

PCR	B-HPV_Lab_Technique
products	O
were	O
characterized	O
by	O
2	O
%	O
agarose	O
gel	O
electrophoresis	O
and	O
visualized	O
under	O
UV	O
transillumination	O
after	O
ethidium	O
bromide	O
staining	O
.	O

As	O
positive	O
controls	O
for	O
ampliﬁcation	O
,	O
full	O
genomes	O
of	O
HPV16	O
and	O
18	O
(	O
kindly	O
donated	O
by	O
Prof	O
.	O

Michelle	O
de	O
Vil	O
-	O
liers	O
,	O
German	O
Cancer	O
Research	O
Centre	O
,	O
Heidelberg	O
,	O
Germany	O
)	O
were	O
used	O
,	O
and	O
nuclease	O
-	O
free	O
water	O
was	O
used	O
as	O
negative	O
control	O
.	O

RNA	O
extraction	O
and	O
HPV	O
-	O
16	O
E6	O
/	O
E7	O
transcript	O
detection	O

RNA	O
puriﬁcation	O
was	O
carried	O
out	O
using	O
the	O
High	O
Pure	O
RNA	O
parafﬁn	O
kit	O
(	O
Roche	O
)	O
,	O
following	O
the	O
manufacturer	O
'	O
s	O
instructions	O
.	O

The	O
RNA	O
obtain	O
-	O
ed	O
was	O
suspended	O
in	O
50	O
μL	O
of	O
TE	O
buffer	O
(	O
10	O
mM	O
Tris–Cl	O
,	O
1	O
mM	O
EDTA	O
)	O
and	O
stored	O
at	O
−80	O
°C	O
until	O
use	O
.	O

The	O
cDNA	O
preparation	O
was	O
made	O
as	O
fol	O
-	O
lows	O
:	O
100	O
ng	O
of	O
puriﬁed	O
RNA	O
was	O
transformed	O
to	O
cDNA	O
using	O
RNAsin	O
1	O
U	O
/	O
μL	O
(	O
Promega	O
,	O
USA	O
)	O
;	O
1	O
×	O
buffer	O
TR	O
(	O
Promega	O
,	O
USA	O
)	O
;	O
10	O
μg	O
/	O
μL	O
random	O
primers	O
(	O
Promega	O
,	O
USA	O
)	O
;	O
20	O
U	O
/	O
μL	O
MMLV	O
(	O
Promega	O
,	O
USA	O
)	O
and	O
2	O
mM	O
dNTPs	O
in	O
a	O
ﬁnal	O
volume	O
of	O
20	O
μL	O
.	O

MMLV	O
negative	O
controls	O
were	O
includ	O
-	O
ed	O
.	O

The	O
reaction	O
mixture	O
was	O
incubated	O
at	O
37	O
°C	O
for	O
1	O
h	O
,	O
70	O
°C	O
for	O
15	O
min	O

and	O
stored	O
at	O
−20	O
°C	O
.	O

We	O
used	O
GAPDH	O
ampliﬁcation	O
as	O
an	O
inner	O
consti	O
-	O
tutive	O
expression	O
control	O
.	O

The	B-HPV_Lab_Technique
E6	I-HPV_Lab_Technique
and	I-HPV_Lab_Technique
E7	I-HPV_Lab_Technique
transcription	I-HPV_Lab_Technique
detection	I-HPV_Lab_Technique
was	I-HPV_Lab_Technique
carried	I-HPV_Lab_Technique
out	I-HPV_Lab_Technique
using	I-HPV_Lab_Technique
transcriptase	I-HPV_Lab_Technique
-	I-HPV_Lab_Technique
reverse	I-HPV_Lab_Technique
PCR	I-HPV_Lab_Technique
according	O
to	O
a	O
previously	O
described	O
method	O
(	O
)	O
.	O

CDKN2A	O
promoter	O
methylation	O

The	O
CDKN2A	O
promoter	O
methylation	O
was	O
evaluated	O
in	O
oral	O
carcino	O
-	O
mas	O
using	O
methylation	B-HPV_Lab_Technique
-	I-HPV_Lab_Technique
speciﬁc	I-HPV_Lab_Technique
PCR	I-HPV_Lab_Technique
(	I-HPV_Lab_Technique
MSP	I-HPV_Lab_Technique
)	O
according	O
to	O
previously	O
re	O
-	O
ported	O
methods	O
(	O
)	O
.	O

MYOD1	O
ampliﬁcation	O
was	O
used	O
as	O
an	O
inner	O
positive	O
control	O
.	O

Hela	O
cells	O
(	O
harboring	O
HPV	O
-	O
18	O
ge	O
-	O
nomes	O
)	O
treated	O
with	O
SssI	O
methylase	O
were	O
used	O
as	O
positive	O
controls	O
and	O
nuclease	O
-	O
free	O
water	O
was	O
used	O
as	O
a	O
negative	O
control	O
.	O

Immunohistochemistry	B-HPV_Lab_Technique

Sections	O
of	O
4	O
μm	O
thickness	O
from	O
parafﬁn	O
blocks	O
of	O
each	O
case	O
were	O
ob	O
-	O
tained	O
and	O
collected	O
in	O
positively	O
charged	O
slides	O
(	O
Lab	O
Cellpath	O
,	O
En	O
-	O
gland	O
)	O
.	O

Later	O
they	O
were	O
deparafﬁnized	O
in	O
xylene	O
and	O
rehydrated	O
in	O
descending	O
alcohols	O
to	O
distilled	O
water	O
.	O

Immunohistochemical	O
staining	O
was	O
performed	O
using	O
the	O
streptavidin–avidin–biotin	O
complex	O
(	O
ABC	O
)	O
and	O
the	O
reaction	O
was	O
visualized	O
with	O
diaminobenzidine	O
tetrahydrochlo	O
-	O
ride	O
(	O
DAB	O
)	O
.	O

Sections	O
were	O
placed	O
in	O
sodium	O
citrate	O
buffer	O
(	O
pH	O
6	O
)	O
for	O
45	O
min	O
in	O
a	O
pressure	O
cooker	O
for	O
antigen	O
retrieval	O
,	O
and	O
then	O
were	O
washed	O
with	O
PBS	O
for	O
5	O
min	O
.	O

Endogenous	O
peroxidase	O
activity	O
was	O
blocked	O
by	O
in	O
-	O
cubating	O
the	O
sections	O
in	O
3	O
%	O
hydrogen	O
peroxide	O
in	O
methanol	O
at	O
room	O
temperature	O
for	O
30	O
min	O
.	O

The	O
sections	O
were	O
pre	O
-	O
incubated	O
with	O
horse	O
serum	O
for	O
20	O
min	O
at	O
room	O
temperature	O
and	O
then	O
incubated	O
for	O
30	O
min	O
with	O
primary	O
antibodies	O
;	O
p53	O
(	O
Cell	O
Marque	O
Laboratory	O
,	O
USA	O
.	O

R	O
.	O
T	O
.	O
U	O
.	O
dilu	O
-	O
tion	O
)	O
;	O
p16	O
(	O
Biogenex	O
Laboratory	O
,	O
USA	O
.	O

R	O
.	O
T	O
.	O
U	O
.	O
dilution	O
)	O
,	O
pRb	O
(	O
Thermo	O
laboratory	O
,	O
USA	O
.	O
1	O
:	O
50	O
dilution	O
)	O
and	O
Ki	O
-	O
67	O
(	O
Cell	O
Marque	O
Laboratory	O
,	O
USA	O
.	O

R	O
.	O
T	O
.	O
U	O
.	O
dilution	O
)	O
,	O
in	O
a	O
moist	O
chamber	O
at	O
37	O
°C	O
.	O

Sections	O
were	O
then	O
washed	O
with	O
PBS	O
for	O
5	O
min	O
and	O
incubated	O
with	O
biotinylated	O
secondary	O
antibody	O
for	O
30	O
min	O
at	O
37	O
°C	O
and	O
then	O
with	O
peroxidase	O
-	O
conjugated	O
streptavidin	O
(	O
Universal	O
Detection	O
System	O
Vectastain	O
Elite	O
Kit	O
wide	O
spec	O
-	O
trum	O
ABC	O
-	O
HRP	O
,	O
RTU	O
,	O
Vector	O
-	O
USA	O
,	O
EE	O
.	O
UU	O
)	O
for	O
20	O
min	O
at	O
37	O
°C	O
.	O

The	O
reac	O
-	O
tion	O
was	O
ﬁnally	O
visualized	O
with	O
diaminobenzidine	O
(	O
DAB	O
)	O
and	O
staining	O
with	O
Harris	O
hematoxylin	O
.	O

Negative	O
controls	O
were	O
obtained	O
by	O
substitu	O
-	O
tion	O
of	O
the	O
primary	O
antibody	O
with	O
PBS	O
.	O

The	O
immunostaining	O
was	O
evaluated	O
and	O
interpreted	O
by	O
an	O
experienced	O
oral	O
pathologist	O
.	O

The	O
immunopositive	O
cells	O
were	O
evaluated	O
using	O
an	O
Olympus	O
BX41	O
micro	O
-	O
scope	O
using	O
40×	O
and	O
ﬁve	O
areas	O
were	O
selected	O
in	O
a	O
non	O
-	O
random	O
manner	O
in	O
neoplastic	O
epithelia	O
areas	O
with	O
a	O
higher	O
positive	O
labeling	O
.	O

For	O
mutated	O
TP53	O
,	O
Ki67	O
and	O
pRb	O
the	O
signal	O
was	O
considered	O
positive	O
when	O
the	O
nucle	O
-	O
us	O
was	O
stained	O
without	O
considering	O
signal	O
intensity	O
.	O

For	O
p16	O
,	O
the	O
signal	O
was	O
considered	O
positive	O
when	O
the	O
nucleus	O
and	O
cytoplasm	O
were	O
stained	O
without	O
considering	O
intensity	O
.	O

The	O
ﬁelds	O
were	O
photographed	O
using	O
an	O
Olympus	O
BX41	O
microscope	O
using	O
the	O
software	O
Micrometrics	O
SE	O
Premi	O
-	O
um	O
program	O
.	O

One	O
thousand	O
neoplastic	O
epithelial	O
cells	O
were	O
counted	O
using	O
the	O
Image	O
J	O
software	O
,	O
determining	O
the	O
number	O
of	O
positive	O
epithe	O
-	O
lial	O
cells	O
for	O
each	O
of	O
the	O
used	O
antibodies	O
.	O

Statistical	O
analysis	O

Shapiro–Wilk	O
test	O
was	O
used	O
for	O
an	O
exploratory	O
normality	O
analy	O
-	O
sis	O
of	O
the	O
data	O
.	O

To	O
determine	O
differences	O
in	O
gender	O
,	O
age	O
and	O
differ	O
-	O
entiation	O
grade	O
between	O
HPV	O
positive	O
and	O
negative	O
OSCCs	O
the	O
Fischer	O
'	O
s	O
exact	O
test	O
was	O
used	O
.	O

To	O
determine	O
the	O
association	O
among	O
HPV16	O
/	O
18	O
presence	O
and	O
p16	O
,	O
pRb	O
,	O
p53	O
and	O
Ki	O
-	O
67	O
positive	O
OSCCs	O
the	O
Mann–Whitney	O
test	O
was	O
used	O
.	O

The	O
results	O
were	O
expressed	O
as	O
median	O
and	O
interquartile	O
range	O
.	O

A	O
p	O
-	O
value	O
less	O
than	O
0	O
.	O
05	O
was	O
con	O
-	O
sidered	O
statistically	O
signiﬁcant	O
.	O

All	O
of	O
the	O
tests	O
were	O
determined	O
using	O
the	O
Stata	O
11	O
.	O
0	O
software	O
.	O

